164 related articles for article (PubMed ID: 17768111)
1. Reversal of acute renal failure by bortezomib-based chemotherapy in patients with multiple myeloma.
Ludwig H; Drach J; Graf H; Lang A; Meran JG
Haematologica; 2007 Oct; 92(10):1411-4. PubMed ID: 17768111
[TBL] [Abstract][Full Text] [Related]
2. Rapid improvement in renal function in patients with multiple myeloma and renal failure treated with bortezomib.
Qayum A; Aleem A; Al Diab AR; Niaz F; Al Momen AK
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):63-8. PubMed ID: 20061695
[TBL] [Abstract][Full Text] [Related]
3. [Safety evaluation of bortezomib in multiple myeloma patients with severe renal failure].
Muta T; Nakanishi H; Yasunaga M; Senba S; Murakami H; Kan S; Ueda Y; Fujisaki T
Gan To Kagaku Ryoho; 2011 Feb; 38(2):237-41. PubMed ID: 21368487
[TBL] [Abstract][Full Text] [Related]
4. Reversibility of renal impairment in patients with multiple myeloma treated with bortezomib-based regimens: identification of predictive factors.
Dimopoulos MA; Roussou M; Gavriatopoulou M; Zagouri F; Migkou M; Matsouka C; Barbarousi D; Christoulas D; Primenou E; Grapsa I; Terpos E; Kastritis E
Clin Lymphoma Myeloma; 2009 Aug; 9(4):302-6. PubMed ID: 19717380
[TBL] [Abstract][Full Text] [Related]
5. Bortezomib-associated fatal liver failure in a haemodialysis patient with multiple myeloma.
Cornelis T; Beckers EA; Driessen AL; van der Sande FM; Koek GH
Clin Toxicol (Phila); 2012 Jun; 50(5):444-5. PubMed ID: 22462599
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib-induced acute pancreatitis in a patient with multiple myeloma.
Wang HH; Tsui J; Wang XY; Liu SS; Li J
Leuk Lymphoma; 2014 Jun; 55(6):1404-5. PubMed ID: 23927397
[No Abstract] [Full Text] [Related]
7. Complete atrioventricular block secondary to bortezomib use in multiple myeloma.
Lee WS; Kim DH; Shin SH; Woo SI; Kwan J; Park KS; Park SD; Yi HG; Jeon SH
Yonsei Med J; 2011 Jan; 52(1):196-8. PubMed ID: 21155055
[TBL] [Abstract][Full Text] [Related]
8. Current therapy of myeloma induced renal failure.
Gertz MA
Leuk Lymphoma; 2008 May; 49(5):833-4. PubMed ID: 18452070
[No Abstract] [Full Text] [Related]
9. Bortezomib-related colon mucositis in a multiple myeloma patient.
Siniscalchi A; Tendas A; Ales M; Fratoni S; Cupelli L; Dentamaro T; Scaramucci L; Giovannini M; Caravita T; Santeusanio G; Niscola P; de Fabritiis P
Support Care Cancer; 2009 Apr; 17(4):325-7. PubMed ID: 19172306
[No Abstract] [Full Text] [Related]
10. Rapid response to high-dose steroids of severe bortezomib-related pulmonary complication in multiple myeloma.
Zappasodi P; Dore R; Castagnola C; Astori C; Varettoni M; Mangiacavalli S; Lazzarino M; Corso A
J Clin Oncol; 2007 Aug; 25(22):3380-1. PubMed ID: 17664489
[No Abstract] [Full Text] [Related]
11. The safety and efficacy of bortezomib in relapsed multiple myeloma.
Jagannath S
Clin Adv Hematol Oncol; 2006 May; 4(5):2-3; discussion 8; suppl 13. PubMed ID: 16830423
[No Abstract] [Full Text] [Related]
12. Severe irreversible bilateral hearing loss after bortezomib (VELCADE) therapy in a multiple myeloma (MM) patient.
Engelhardt M; Müller AM; Maier W; Wäsch R
Leukemia; 2005 May; 19(5):869-70. PubMed ID: 15772697
[No Abstract] [Full Text] [Related]
13. Bortezomib increases survival of patients with relapsed multiple myeloma.
Health News; 2005 Sep; 11(9):9. PubMed ID: 16211682
[No Abstract] [Full Text] [Related]
14. Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens.
Roussou M; Kastritis E; Migkou M; Psimenou E; Grapsa I; Matsouka C; Barmparousi D; Terpos E; Dimopoulos MA
Leuk Lymphoma; 2008 May; 49(5):890-5. PubMed ID: 18464107
[TBL] [Abstract][Full Text] [Related]
15. [Effectiveness of bortezomib and bortezomib-containing programs for the treatment of recurrent and resistant multiple myeloma].
Mitina TA; Golenkov AK; Kataeva EV; Lutskaia TD; Trifonova EV; Klinushkina EF
Ter Arkh; 2010; 82(7):57-61. PubMed ID: 20853611
[TBL] [Abstract][Full Text] [Related]
16. [Bortezomib-based regimen for the treatment of 110 multiple myeloma patients].
Yang GZ; Chen WM
Zhonghua Yi Xue Za Zhi; 2010 Oct; 90(38):2671-4. PubMed ID: 21162894
[TBL] [Abstract][Full Text] [Related]
17. Hyperlipidemia in a myeloma patient after bortezomib treatment.
Gozzetti A; Fabbri A; Defina M; Chitarrelli I; Bocchia M
Leuk Res; 2010 Sep; 34(9):e250. PubMed ID: 20363499
[No Abstract] [Full Text] [Related]
18. Acute pancreatitis caused by bortezomib.
Solakoglu T; Akyol P; Guney T; Dilek I; Atalay R; Koseoglu H; Akin E; Demirezer Bolat A; Buyukasik NS; Ersoy O
Pancreatology; 2013; 13(2):189-90. PubMed ID: 23561979
[TBL] [Abstract][Full Text] [Related]
19. Optimizing bortezomib treatment in patients with relapsed multiple myeloma.
Richardson P
Clin Adv Hematol Oncol; 2006 May; 4(5):4-5; discussion 8; suppl 13. PubMed ID: 16832859
[No Abstract] [Full Text] [Related]
20. Bortezomib and bilateral herpes zoster.
di Meo N; Bergamo S; Dondas A; Trevisan G
Acta Dermatovenerol Alp Pannonica Adriat; 2012; 21(1):21-2. PubMed ID: 22584902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
